Loading...
Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
Pawnikar, Shristi Miao, Yinglong
Pawnikar, Shristi
Miao, Yinglong
Citations
Altmetric:
Abstract
Chemokine receptors are key G-protein-coupled receptors (GPCRs) that control cell migration in immune system responses, development of cardiovascular and central nervous systems, and numerous diseases. In particular, the CXCR4 chemokine receptor promotes metastasis, tumor growth and angiogenesis in cancers. CXCR4 is also used as one of the two co-receptors for T-tropic HIV-1 entry into host cells. Therefore, CXCR4 serves as an important therapeutic target for treating cancers and HIV infection. Apart from the CXCL12 endogenous peptide agonist, previous studies suggested that the first 17 amino acids of CXCL12 are sufficient to activate CXCR4. Two 17-residue peptides with positions 1–4 mutated to RSVM and ASLW functioned as super and partial agonists of CXCR4, respectively. However, the mechanism of peptide agonist binding in CXCR4 remains unclear. Here, we have investigated this mechanism through all-atom simulations using a novel Peptide Gaussian accelerated molecular dynamics (Pep-GaMD) method. The Pep-GaMD simulations have allowed us to explore representative binding conformations of each peptide and identify critical low-energy states of CXCR4 activated by the super versus partial peptide agonists. Our simulations have provided important mechanistic insights into peptide agonist binding in CXCR4, which are expected to facilitate rational design of new peptide modulators of CXCR4 and other chemokine receptors.
Description
Date
2022-03-11
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Chemokine receptors, Peptide, Agonists, Drug design, Peptide Gaussian accelerated molecular dynamics, Enhanced sampling
Citation
Pawnikar, S., & Miao, Y. (2022). Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor. Frontiers in molecular biosciences, 9, 821055. https://doi.org/10.3389/fmolb.2022.821055